These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7533371

  • 1. Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.
    Armstrong VW, Kaltefleiter M, Luy-Kaltefleiter M, Schütz E, Wieland E, Loss M, Winkler M, Ringe B, Oellerich M.
    Transplant Proc; 1995 Feb; 27(1):1201-3. PubMed ID: 7533371
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract] [Full Text] [Related]

  • 4. Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
    Lemmens HP, Langrehr JM, Blumhardt G, Lohmann R, Knoop M, Verschl J, Schattenfroh N, Neuhaus R, Hopf U, Bechstein WO.
    Transplant Proc; 1994 Dec; 26(6):3622-3. PubMed ID: 7527983
    [No Abstract] [Full Text] [Related]

  • 5. Intensive care after orthotopic liver transplantation.
    Sun CK, Chen CL, Kuo YC, Chen YS.
    Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
    [No Abstract] [Full Text] [Related]

  • 6. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES, So S, Jendrisak MD, Perdrizet GA, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract] [Full Text] [Related]

  • 7. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM, Lohmann R, Raakow R, Jonas S, Klupp J, Bechstein WO, Neuhaus R, Neuhaus P.
    Transplant Proc; 2001 May; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract] [Full Text] [Related]

  • 10. Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation.
    Lohmann R, Langrehr JM, Klupp J, Neumann U, Guckelberger O, Müller AR, Nüssler NC, Jonas S, Lang M, Settmacher U, Bechstein WO, Neuhaus PJ.
    Transplant Proc; 1999 Apr; 31(1-2):380. PubMed ID: 10083151
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
    Bismuth H.
    Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M, Winkler M, Schneider A, Brinkmann C, Manns M, Ringe B, Pichlmayr R.
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract] [Full Text] [Related]

  • 16. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L, Figueras J, Ramos E, Baliellas C, Torras J, Rafecas A, Fabregat J, Lama C, Ibañez L, Jaurrieta E.
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N, Lange D, Bechstein WO, Blumhardt G, Lohmann R, Neuhaus P.
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.